{
    "organizations": [],
    "uuid": "bd3df37c3381e3b4bdb4db160b7e66f3a72b0d36",
    "author": "",
    "url": "https://www.reuters.com/article/brief-xbiotech-announces-upcoming-phase/brief-xbiotech-announces-upcoming-phase-2-clinical-studies-in-dermatology-idUSFWN1RT0AZ",
    "ord_in_thread": 0,
    "title": "BRIEF-XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 21 PM / Updated 10 minutes ago BRIEF-XBiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology Reuters Staff \n  XBiotech Inc: \n* XBIOTECH ANNOUNCES UPCOMING PHASE 2 CLINICAL STUDIES IN DERMATOLOGY \n* XBIOTECH INC - CO WOULD EVALUATE A NEW SUBCUTANEOUS FORMULATION OF COâ€™S TRUE HUMAN MONOCLONAL ANTIBODY, MABP1, IN TWO SEPARATE PHASE 2 STUDIES \n* XBIOTECH INC - UPCOMING PHASE 2 CLINICAL STUDIES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS (AD) AND HIDRADENITIS SUPPURATIVA (HS)  ",
    "published": "2018-04-16T15:18:00.000+03:00",
    "crawled": "2018-04-16T15:40:48.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "upcoming",
        "phase",
        "clinical",
        "study",
        "dermatology",
        "reuters",
        "staff",
        "xbiotech",
        "inc",
        "xbiotech",
        "announces",
        "upcoming",
        "phase",
        "clinical",
        "study",
        "dermatology",
        "xbiotech",
        "inc",
        "co",
        "would",
        "evaluate",
        "new",
        "subcutaneous",
        "formulation",
        "co",
        "true",
        "human",
        "monoclonal",
        "antibody",
        "mabp1",
        "two",
        "separate",
        "phase",
        "study",
        "xbiotech",
        "inc",
        "upcoming",
        "phase",
        "clinical",
        "study",
        "patient",
        "moderate",
        "severe",
        "atopic",
        "dermatitis",
        "ad",
        "hidradenitis",
        "suppurativa",
        "h"
    ]
}